Elisa Hertzan

Plan to scale back Medicare’s protected drug classes would hurt epilepsy patients

By Published: February 27, 2019 6:12 PM CT

Doctors need the discretion to choose the anticonvulsant drugs most effective at controlling seizures of epileptic patients. Changes proposed by the Centers for Medicare and Medicaid Services could exclude certain drugs from coverage.

Topics

Centers for Medicare and Medicaid Services Epilepsy Medicare Part D

Comment On This Story

Email Editions

Sign up for our morning and evening editions, plus breaking news.